- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06162052
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
Study Overview
Detailed Description
This is a prospective single center randomized trial comparing a traditional approach to physical therapy to a technology-enhanced approach following a burn. We hypothesize that with the implementation of a novel telerehabilitation program incorporating technology enhancement, range of motion and quality of life can be improved. To test the hypothesis in future grant applications, this pilot study will be used to determine feasibility, collect preliminary data, vet endpoints, and gain patient feedback. To achieve these necessary goals, we will compare two methods of supporting home performance of prescribed physical and occupational therapy: Standard (S): patients will be equipped with paper instructions for their physical therapy exercises; and Technology-Enhanced (TE) support: patients will be given paper instructions, set up with a habit and productivity application (Avocation) that gamifies tasks and tracks achievements, a Fitbit activity tracker, a logbook, and have virtual movement therapy once weekly with an exercise physiologist for a total of four weeks.
Specific Aim 1: To determine whether range of motion is altered with TE. Range of motion in the affected joint(s) will be measured by goniometry (self-reported by patient and measured by study staff in the clinic)
Specific Aim 2: To determine whether TE with prescribed movement affects scar, pain, and quality of life.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Celeste Finnerty, PhD
- Phone Number: (409)772-1011
- Email: ccfinner@utmb.edu
Study Contact Backup
- Name: Steven E. Wolf, MD
- Phone Number: (409)772-1011
- Email: swolf@utmb.edu
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77555
- Recruiting
- University of Texas Medical Branch
-
Contact:
- Celeste Finnerty, PhD
- Phone Number: 409-772-1011
- Email: ccfinner@utmb.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults: ≥18 to ≤79 years of age
- Not participating in another interventional trial
- Admitted to the Blocker Burn Unit for treatment of initial burn
- Subject is able and willing to follow the protocol requirements
- Burn wound / scar / contracture occurring across at least one joint.
- Has regular access to smart phone, tablet, or computer with internet access.
Exclusion Criteria:
- Any medical condition that, in the opinion of the investigator or physician, would place the subject at increased risk for participation.
- Concurrent participation on another interventional clinical trial
- History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
- Patients without internet access.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A Standard of Care group (SOC)
Participants will receive standard of care education by the physical or occupational therapist regarding performance of the prescribed movements prior to discharge.
Participants will complete the study about 6 months after discharge.
|
Technology will be used to enhance rehabilitation.
|
Experimental: A Standard of Care group (SOC) combined with technology enhancement
Participants will receive standard of care education by the physical or occupational therapist regarding performance of the prescribed movements prior to discharge.
Participants will undergo additional training in the use of a goniometer to measure range of motion at home and record the measurement once a week for 6 months.
Participants will engage in 4 virtual sessions as well as wear a Fitbit
|
Technology will be used to enhance rehabilitation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in range of motion, measured with a goniometer
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Patient will be asked to bend the affected joint, and the goniometer held next to the joint to measure the angle.
The range of motion for the opposite joint will be measured as well.
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scar Volume
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
3D photo taken with LifeViz 3DII camera.
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Elasticity, color, temperature, trans epidermal water loss, and scar thickness
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Measured with Dermalab combo (Cortex Technology, Denmark); each probe is held with constant pressure on the skin or scar surface for one minute; multiple measures are conducted to reduce variability.
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Blood Flow
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
A laser speckle device will be used to measure blood flow without contact.
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Patient and Observer Scar Assessment Scale v2.0
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
The scale consists of six items rated from 1 to 10, where 1 is "normal skin" and 10 is the "worst imaginable scar".
The observer (i.e., investigator) evaluates scar vascularity, pigmentation, thickness, relief, pliability, and surface area.
The scores of each of the six items are summed for a total score (range 6 to 60).
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Pain Visual Analog Scale (VAS) Score
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Pain severity scores at rest will be assessed by use of a visual analog scale (VAS; 0 = no pain, 100 = worst pain imaginable).
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Post Interview
Time Frame: 6 months (± 2 weeks) post discharge
|
At the conclusion of each patient's participation, they will meet with an investigator or delegated study staff for a brief non-structured interview to discuss participation in the study including improvements for follow-up studies.
|
6 months (± 2 weeks) post discharge
|
Overall Activity
Time Frame: Months 2, 4, and 5 (+15 days, each timepoint) in addition to 1, 3, & 6 months after discharge.
|
To be captured via Fitbit on a daily basis to gauge overall activity.
These data will be correlated with the pain scale as reduced activity is associated with pain.
|
Months 2, 4, and 5 (+15 days, each timepoint) in addition to 1, 3, & 6 months after discharge.
|
Itch Scale
Time Frame: Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
A Visual Analog Scale will be used for patients to rate their itch from 0 to 100.
(VAS; 0 = no itch, 100 = worst itch imaginable).
|
Prior to planned discharge or during first week post- discharge (Baseline), and at clinic visits approximately 1, 3, & 6 months after discharge (±15 days, each timepoint)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Celeste Finnerty, PhD, University of Texas
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-0331
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
MediWound LtdCompletedThermal BurnsUnited States, Israel, Belgium, Czechia, Georgia, Germany, Italy, Romania
-
Sun Yat-sen UniversityCompleted
-
Virginia Commonwealth UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
MediWound LtdActive, not recruitingThermal BurnsUnited States, United Kingdom, Spain, Georgia, Belgium, Poland, Germany, Hungary, India, Italy, Netherlands, Romania, Slovakia, Ukraine
-
ShiCang YuNot yet recruitingLarge Area BurnsChina
Clinical Trials on Tele-Rehabilitation
-
Clalit Health ServicesTerminated
-
Taipei Medical University Shuang Ho HospitalCompleted
-
Centro Universitário Augusto MottaRecruiting
-
LIAO PengRecruitingBurns | Children | Scar | Tele-rehabilitationChina
-
Kexin Wang, MMNot yet recruitingAnterior Cruciate Ligament Reconstruction | Tele-rehabilitation
-
National University, SingaporeAng Mo Kio - Thye Hua Kwan Hospital; Singapore General Hospital; Singapore Millennium...Completed
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
Superior UniversityRecruiting
-
Hull University Teaching Hospitals NHS TrustRecruiting
-
Hasan Kalyoncu UniversityCompleted